193 related articles for article (PubMed ID: 14526205)
1. Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
Gebo KA; Diener-West M; Moore RD
J Acquir Immune Defic Syndr; 2003 Oct; 34(2):165-73. PubMed ID: 14526205
[TBL] [Abstract][Full Text] [Related]
2. Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy.
Gebo KA; Diener-West M; Moore RD
J Acquir Immune Defic Syndr; 2001 Jun; 27(2):143-52. PubMed ID: 11404536
[TBL] [Abstract][Full Text] [Related]
3. Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states.
Gebo KA; Fleishman JA; Moore RD
J Acquir Immune Defic Syndr; 2005 Dec; 40(5):609-16. PubMed ID: 16284539
[TBL] [Abstract][Full Text] [Related]
4. Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001.
Betz ME; Gebo KA; Barber E; Sklar P; Fleishman JA; Reilly ED; Christopher Mathews W;
Med Care; 2005 Sep; 43(9 Suppl):III3-14. PubMed ID: 16116304
[TBL] [Abstract][Full Text] [Related]
5. Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration.
May MT; Justice AC; Birnie K; Ingle SM; Smit C; Smith C; Neau D; Guiguet M; Schwarze-Zander C; Moreno S; Guest JL; Monforte Ad; Tural C; Gill MJ; Bregenzer A; Kirk O; Saag M; Sterling TR; Crane HM; Sterne JA
J Acquir Immune Defic Syndr; 2015 Jul; 69(3):348-54. PubMed ID: 25848927
[TBL] [Abstract][Full Text] [Related]
6. Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study.
Weis N; Lindhardt BO; Kronborg G; Hansen AB; Laursen AL; Christensen PB; Nielsen H; Moller A; Sorensen HT; Obel N
Clin Infect Dis; 2006 May; 42(10):1481-7. PubMed ID: 16619163
[TBL] [Abstract][Full Text] [Related]
7. Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.
Smit C; van den Berg C; Geskus R; Berkhout B; Coutinho R; Prins M
J Acquir Immune Defic Syndr; 2008 Feb; 47(2):221-5. PubMed ID: 18223361
[TBL] [Abstract][Full Text] [Related]
8. Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort.
Di Biagio A; Nicolini LA; Lorenzini P; Puoti M; Antinori A; Cozzi-Lepri A; Gori A; Vecchiet J; Mussini C; Andreoni M; Viscoli C; d'Arminio Monforte A; For The Icona Foundation Study Group
HIV Clin Trials; 2014; 15(4):151-60. PubMed ID: 25143024
[TBL] [Abstract][Full Text] [Related]
9. Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection.
Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
Int J STD AIDS; 2005 Jan; 16(1):42-8. PubMed ID: 15705272
[TBL] [Abstract][Full Text] [Related]
10. Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women.
Gardner LI; Klein RS; Szczech LA; Phelps RM; Tashima K; Rompalo AM; Schuman P; Sadek RF; Tong TC; Greenberg A; Holmberg SD;
J Acquir Immune Defic Syndr; 2003 Nov; 34(3):320-30. PubMed ID: 14600579
[TBL] [Abstract][Full Text] [Related]
11. Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART.
Lumbreras B; Jarrín I; del Amo J; Pérez-Hoyos S; Muga R; García-de la Hera M; Ferreros I; Sanvisens A; Hurtado I; Hernández-Aguado I
AIDS; 2006 Jan; 20(1):111-6. PubMed ID: 16327326
[TBL] [Abstract][Full Text] [Related]
12. Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: increasing rates of HCV diagnosis but not of HCV seroconversions.
Sobrino-Vegas P; Monge Corella S; Serrano-Villar S; Gutiérrez F; Blanco JR; Santos I; del Romero J; Segura F; Portilla J; Guillén SM; del Amo J;
PLoS One; 2014; 9(12):e116226. PubMed ID: 25549224
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort.
Braitstein P; Justice A; Bangsberg DR; Yip B; Alfonso V; Schechter MT; Hogg RS; Montaner JS
AIDS; 2006 Feb; 20(3):323-31. PubMed ID: 16439865
[TBL] [Abstract][Full Text] [Related]
14. Risk factors associated with inpatient hospital utilization in HIV-positive individuals and relationship to HIV care engagement.
Kerr JC; Stephens TG; Gibson JJ; Duffus WA
J Acquir Immune Defic Syndr; 2012 Jun; 60(2):173-82. PubMed ID: 22293549
[TBL] [Abstract][Full Text] [Related]
15. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB
Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414
[TBL] [Abstract][Full Text] [Related]
16. The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy.
Klein MB; Lalonde RG; Suissa S
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):365-72. PubMed ID: 12843748
[TBL] [Abstract][Full Text] [Related]
17. Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.
Voirin N; Trépo C; Miailhes P; Touraine JL; Chidiac C; Peyramond D; Livrozet JM; Ritter J; Chevallier P; Fabry J; Allard R; Vanhems P
J Viral Hepat; 2004 Nov; 11(6):559-62. PubMed ID: 15500557
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic.
Wandeler G; Gsponer T; Bregenzer A; Günthard HF; Clerc O; Calmy A; Stöckle M; Bernasconi E; Furrer H; Rauch A;
Clin Infect Dis; 2012 Nov; 55(10):1408-16. PubMed ID: 22893583
[TBL] [Abstract][Full Text] [Related]
19. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
Sogaard OS; Lohse N; Gerstoft J; Kronborg G; Ostergaard L; Pedersen C; Pedersen G; Sørensen HT; Obel N
Clin Infect Dis; 2008 Nov; 47(10):1345-53. PubMed ID: 18834317
[TBL] [Abstract][Full Text] [Related]
20. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
